Oncology

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.

Filter our product list:
API
Antigen / Target
Therapeutic Areas
1
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
–
2 mg
-80°C
2021.07
145,00 
view product
Max: 10
Min: 2
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
–
4 mg
-80°C
2026.04
202,00 
view product
Max: 10
Min: 2
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Rixathon®
10 mg/mL
–
2 mg
-80 °C
2026.03
245,00 
view product
Max: 10
Min: 2
Step: 1
CD3
,
DLL3
Bi-specific T-cell engager
Imdelltra®
2,38 mg/mL
–
0,25 mg
-80°C
2027.06
1.511,45 
view product
Max: 10
Min: 1
Step: 1
CD3
,
TCR targeting domain
Bispecific fusion protein
Kimmtrak®
0,2 mg/mL
–
0.01 mg
tba
tba
4.602,00 
view product
Max:
Min: 4
Step: 1
B cell maturation antigen
,
CD3
Bispecific Antibody
Tecvayli®
10 mg/mL
–
1 mg
-80°C
2024.10
410,00 
view product
Max: 10
Min: 1
Step: 1
Tissue factor (TF)
Antibody-drug conjugate (ADC)
Tivdak®
10 mg/mL
–
1 mg
tba
tba
1.665,00 
view product
Max: 10
Min: 7
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Herzuma®
21 mg/mL
–
6 mg
tba
tba
356,00 
view product
Max:
Min: 7
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ontruzant®
21 mg/mL
–
2 mg
tba
tba
159,00 
view product
Max:
Min: 15
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Kanjinti®
21 mg/mL
–
6 mg
-80°C
2025.01
367,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Zercepac®
21 mg/mL
–
6 mg
-80°C
2026.08
367,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
–
2 mg
-80°C
2028.11
169,00 
view product
Max: 2
Min: 2
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ogivri®
21 mg/mL
–
6 mg
-80°C
2025.10
451,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Antibody-drug conjugate (ADC)
Enhertu®
20 mg/mL
–
2 mg
-80 °C
2027.05
476,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Antibody-drug conjugate (ADC)
Kadcyla®
20 mg/mL
–
2 mg
-80 °C
2027.10
386,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Trazimera®
21 mg/mL
–
2 mg
-80 °C
2026.09
164,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
–
2 mg
-80°C
2020.08
169,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
–
2 mg
-80°C
2021.02
169,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
–
2 mg
-80°C
2021.08
169,00 
view product
Max: 5
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
–
2 mg
-80°C
2026.12
169,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin Hylecta®
120 mg/mL Trastuzumab + 2000 IU/mL Hyaluronidase
–
30 mg Trastuzumab + 750 IU Hyaluronidase
-80 °C
2026.01
1.582,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
–
2 mg
-80°C
2019.11
169,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
–
2 mg
-80°C
2020.12
169,00 
view product
Max: 10
Min: 2
Step: 1
1 2 3

Not looking for Oncology?

Search our therapeutic molecules product database